Amyotrophic lateral sclerosis fasting plasma levels cysteine inorganic sulfate normal brain contents cysteine Recent reports amyotrophic lateral sclerosis ALS unidentified neurotoxins patients toxic compounds defect cysteine degradation inorganic sulfate production mechanism failure xenobiotics ALS concentrations total cysteine inorganic sulfate plasma age-matched groups ALS patients healthy control subjects differences L-Cysteine putative endogenous neurotoxin ALS present equal concentrations autopsied brain ALS patients controls 